Insmed Inc. buy Wells Fargo & Company
Start price
19.02.25
/
50%
€78.00
Target price
19.02.26
€102.54
Performance (%)
74.36%
End price
20.02.26
€136.00
Summary
This prediction ended on 20.02.26 with a price of €136.00. The BUY prediction by Wells_Fargo___Compan for Insmed Inc. saw massive gains of 74.36%. Wells_Fargo___Compan has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | -0.171% | -0.171% | 5.548% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $85.00 to $107.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten